Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research Team Invents Small-Diameter Artificial Arteries

04.03.2005


A patient needs a small-diameter bypass graft to replace a diseased blood vessel because of the progression of diabetes or the result of smoking.



Due to these chronic health issues, the patient’s veins can no longer be used for such a procedure. While large artificial arteries (10 to 15 millimeters in diameter) have been in use for about 50 years for replacing large blood vessels, development of a small-diameter artificial artery (less than 5 millimeters) has been unsuccessful due to rapid failure when implanted.

Martin Bide, a textile chemist at the University of Rhode Island, Matthew Phaneuf, president of BioSurfaces, Ashland, Mass., and Philip J. Brown of the School of Materials Science and Engineering at Clemson University, have developed a new way to synthesize such grafts from material made of polyester and collagen. A Phase I Small Business Innovative Research Grant (SBIR) from the National Heart, Lung and Blood Institute from the National Institutes of Health funded the research.


The trio said in its research summary that more than 500,000 peripheral bypass and coronary artery bypass grafts are implanted in the United States annually, so the potential annual market for a synthetic bypass graft could exceed $1.5 billion. Up until the team’s work, very little had changed with the technology related to artificial arteries since the mid-1950s, according to Phaneuf.

The polyester and collagen are electrospun into a mesh of ultra-fine fibers. Electrospinning uses electrostatic forces to distort a droplet of polymer solution into a fine filament to be deposited onto a surface. The process allows production of novel synthetic fibers of unusually small diameter and good mechanical properties. Other potential applications include wound dressing materials, artificial organs, and protective clothing. The researchers say the collagen allows the attachment of bioactive proteins that will promote healing and reduce clot formation.

Currently, no clinically available small (5 millimeter in diameter and smaller) vascular grafts can emulate the biological and physical properties of normal arteries. Implanted grafts of currently available materials fail because of clotting and stiffness as related to normal blood vessels. “A small vessel prosthesis (artery graft) that better emulates normal arterial walls would greatly improve the treatment of both peripheral vascular disease and coronary artery disease,” the researchers state in a summary of their research. “This is one of the applications it suits perfectly since conventional fiber extrusion technology is incapable of making such a material i.e., one that can combine proteins and synthetic materials together to form a composite small- scale device with all the right kind of properties,” Brown said.

The technology developed by Phaneuf, Brown and Bide is called “a nanofibrous biocomposite prosthetic vascular graft.” “The first choice for such a procedure is a patient’s own veins,” Bide said, “but when those veins have been damaged as a result of chronic illness, such as diabetes or those conditions related to smoking, then surgeons need an alternative.” “We employ the electrospinning process to create nanofibers with very large surface area for their weight,” Phaneuf said.

Bide said the collagen will be eliminated as the body’s own cells take up spaces in the artery or graft, thus reducing the potential for rejection. “We know through our early research that we can link proteins to the grafts and add anti-clotting treatments, as well as growth factors and other bioactive agents,” Bide said.

The next step for the three researchers, after successful completion of the Phase II SBIR studies, is to find a private company interested in licensing the product to allow for further research and eventual production for the market. “As a scientist, you always want to see an invention fully developed so that it can be used to help people,” Phaneuf said.

| newswise
Further information:
http://www.uri.edu

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>